Common drugs can halt the progression of skin cancer


Common drugs can halt the progression of skin cancer

A recent study by the Brisbane-based QIMR Berghofer Medical Research Institute has found that a regular intake of some anti-inflammatory painkillers including ibuprofen and aspirin could improve patient survival odds by reducing the likelihood of melanomas becoming ulcerated (when the top layer of skin disappears).

It was found that Statins, a popular cholesterol lowering drug, seemed to modify inflammatory mechanisms in the body that often lead to melanomas becoming ulcerated. The study also found that diabetes sufferers were at an increased risk of developing ulcerated melanomas.

It echoes a study released by the University of Queensland which found that adding aspirin to some cancer drugs could increase their effectiveness. The study found that mixing aspirin with the cancer inhibitor drug: Sorafenib, strongly enhanced the effectiveness of treatment of lung cancer and melanomas with RAS genetic mutations.

Chris McMillian, the CEO at Cancer Council Queensland said that “Research into this area is vital to help us better understand how to detect and treat melanomas early to improve survival and reduce long-term effects on patients.”

She went on to advise that “if you notice a new spot on your skin or a change in the size, shape or colour of a spot, it’s important to visit your GP as early detection saves lives.”

Read more about the studies and their findings: HERE and HERE.

news aspirin